Candida dubliniensis and Candida albicans display surface variations consistent with observed intergeneric coaggregation

Revista Iberoamericana de Micologia

Volumn 16, Issue 4, 1999, Pages 187-193

  Jabra Rizk, Mary Ann ^a,c   Falkler Jr , William A ^a   Merz, William G ^b   Kelley, Jacqueline I ^a   Baqui, A A M A ^a   Meiller, Timothy F ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Candida albicans; Candida dubliniensis; Cell wall; Electron microscopy

Indexed keywords

ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CELL DENSITY; CELL GROWTH; CELL MEMBRANE; FUSOBACTERIUM NUCLEATUM; GENETIC VARIABILITY; HYDROPHOBICITY; NONHUMAN;

CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; FUSOBACTERIUM NUCLEATUM;

EID: 0033387808     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Sullivan D, Bennett D, Henman M, et al. Oligonucleotide fingerprinting of isolates of Candida species other than Candida albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J Clin Microbiol 1993; 31: 2124-2133.
2. Sullivan D, Westermemg T, Haynes KA, Bennett D, Coleman D. Candida dubliniensis sp. noy. = phenotypic and molecular characterization of a novel species associated with oral candidiasis in HIV-infected individuals. Microbiology 1995; 141: 1507-1521.
3. Sullivan D, Haynes K, Bille J, et al. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J Clin Microbiol 1997; 35: 960-964.
4. Coleman DC, Sullivan DJ, Bennett DE, Moran GP, Barry HJ, Shanky DB. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 1997; 11: 557-567
5. Kirkpatrick WR, Revankar SG, McAtee RK, et al. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clm Microbiol 1998; 36: 3007-3012
6. Salkin IF, Pruitt WR, Padhye AA, Sullivan D, Coleman D, Pincus DH. Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States. J Clin Microbiol 1998; 36: 1467.
7. Sullivan D, Coleman D. Candida dubliniensis: characteristics and identification. J Clin Microbiol 1998; 38: 329-334.
8. Jabra-Rizk MA, Baqui AAMA, Kelley JI, Falkler Jr, WA, Merz WG, Meiller TF. Identification of Candida dubliniensis in a prospective study of patients in the United States J Clin Microbiol 1999; 37: 321-326.
9. Moran GP, Sullivan DJ, Henman MC, et al. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 1997;41:617-623.
10. Gilfillan GD, Sullivan DJ, Haynes K, Parkinson T, Coleman DC, Gow NAR. Candida dubliniensis: phytogeny and putative virulence factors. Microbiology 1998; 144: 829-838.
11. Moran GP, Sanglard D, Donnelly SM, Shanley D, Sullivan DJ, Coleman DC. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother 1998; 42: 1819-1830.
12. Pfaller MA, Messer SA, Gee S, et al. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J Clin Microbiol 1999;37:870-872.
13. Wingard J, Merz W, Saral R. Candida tropicalis: a major pathogen in immunocompromised patients. Annal Intern Med 1979; 91: 529-543.
14. Wingard JR, Merz WG, Rinaldi G, Johnson TR, Karp JE, Saral R Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Eng J Med 1991; 18: 1274-1277.
15. Merz WG, Khazan U, Jabra-Rizk MA, Wu L-C, Osterhout CJ, Lehmann PF. Strain delineation and epidemiology of Candida (Clavispora) lusitaniae. J Clin Microbiol 1992; 30: 449-454.
16. Vazquez JA, Dembry LM, Sanchez V, et al. Nosocomial Candida glabrata colonization: an epidemiologic study. J Clin Microbiol 1998; 36: 421-426.
17. Antley PP, Hazen KC. Role of yeast cell growth temperature on Candida albicans virulence in mice Infect Immun 1988; 56: 2884-2890.
18. Hazen KC, Lay J-G, Hazen BW, Fu RC. Partial biochemical characterization of cell surface hydrophobicity and hydrophilicity of Candida albicans. Infect Immun 1990; 58: 3469-3476.
19. Lopez-Ribot JL, Casanova M, Martinez JP, Sentandreu R. Characterization of cell wall proteins of yeast and hydrophobic mycelial cells of Candida albicans. Infect Immun 1991; 59: 2324-2332.
20. Shepherd MG. Cell envelope of Candida albicans. CRC Clin Rev Microbiol 1987, 15:7-25.
21. Calderone RA, Braun PC. Adherence and receptor relationships of Candida albicans. Microbiol Rev 1991; 55 1-20
22. Hazen BW, Hazen KC. Dynamic expression of cell surface hydrophobicity during initial yeast cell growth and before germ tube formation of Candida albicans. Infect Immun 1988; 56: 2521-2525.
23. McCourtie J, Douglas LJ Relationship between cell surface composition, adherence, and virulence of Candida albicans. Infect Immun 1984; 45: 6-12.
24. Tokunaga M, Nimi M, Kusamichi M, Koike H. Initial attachment of Candida albicans cells to buccal epithelial cells. Mycopathologia 1990, 111: 61-66.
25. Masuoka J, Hazen KC. Cell wall protein mannosylation determines Candida albicans cell surface hydrophobicity. Microbiology 1997; 143. 3015-3021.
26. Jabra-Rizk MA, Falkler WA Jr, Merz WG, Kelley JI, Baqui AAMA, Meiller TF. Coaggregation of Candida dubliniensis with Fusobacterium nucleatum. J Clin Microbiol 1999, 37: 1464-1468.
27. Glee PM, Sundstrom P, Hazen KC. Expression of surface hydrophobic proteins by Candida albicans in vivo. Infect Immun 1995; 63: 1373-1379.
28. Grimaudo NJ, Nesbitt WE. Coaggregation of Candida albicans with oral Fusobacterium species. Oral Microbiol Immunol 1997; 12: 168-173.
29. Bikandi J, Millan RS, Moragues MD, et al. Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes J Clin Microbiol 1998; 36: 2428-2433.
30. Tokunaga M, Kusamichi M, Koike H. Ultrastructure of outermost layer of cell wall in Candida albicans observed by rapid-freezing technique. J Electron Microsc 1986; 35:237-246
31. Hazen KC. Participation of yeast cell surface hydrophobicity in adherence of Candida albicans to human epithelial cells Infect Immun 1989; 57: 1894-1900.
32. Kusamichi M, Monodane T, Tokunaga M, Koike H. Influence of surrounding media on preservation of cell wall ultrastructure of Candida albicans revealed by low temperature scanning electron microscopy. J Electron Microsc 1990; 39: 477-486.
33. Hazen KC, Brawner DL, Riesselman MH, Jutila MA, Cutler JE. Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissues. Infect Immun 1991; 59: 907-912.
34. Hazen KC, Hazen BW. Hydrophobic surface protein masking by the opportunistic fungal pathogen Candida albicans. Infect Immun 1992; 60: 1499-1508
35. Osumi M. The ultrastructure of yeast: cell wall structure and formation. Micron 1998; 29: 207-233.
36. Fassel TA, Sohnle PG, Kushnaryov VM The use of dimethylsulfoxide for fixation of yeasts for electron microscopy. Biotech Histochem 1997; 72: 268-272.
37. Ponton J, Jones JM. Analysis of cell wall extracts of Candida albicans by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot techniques. Infect Immun 1986; 53: 565-572.